Joel Lewis, President and CEO: Galectin Therapeutics GALT Sell · Filed 01/06

Trade details

Type: Insider sale
Amount: $134,958.84
Shares · price: 37,698 sh · $3.58 a share
Held after: 832,592 sh
Stock: Galectin Therapeutics GALT
Person: Joel LewisPresident and CEO
Trade date: 26/01/06
Filed: 26/01/06
Days to filing: 0 days

Sold 4.3% of holdings

Share of holding sold: 4.3%

Galectin Therapeutics trades, last 26 weeks

What else happened in Galectin Therapeutics around then

Filed or reported within 30 days of the trade day · 25/12/07~02/05

Joel Lewis's recent trades

Joel LewisPresident and CEO
Sell10b5-1 planGalectin Therapeutics
Sell10b5-1 plan
Galectin Therapeutics
GALT
$108.4K
27,731 sh
$108.4K
Filed 01/06
Traded 01/05
Joel LewisPresident and CEO
Sell10b5-1 planGalectin Therapeutics
Sell10b5-1 plan
Galectin Therapeutics
GALT
$78K
18,571 sh
$78K
Filed 01/06
Traded 01/02
Joel LewisPresident and CEO
Planned sale10b5-1 planGalectin Therapeutics
Planned sale10b5-1 plan
Galectin Therapeutics
GALT
$352.8K
84,000 sh
$352.8K
Filed 01/02
Traded 01/02
Joel LewisPresident and CEO
Sell10b5-1 planGalectin Therapeutics
Sell10b5-1 plan
Galectin Therapeutics
GALT
$55.3K
7,829 sh
$55.3K
Filed 25/12/19
Traded 25/12/17
Joel LewisPresident and CEO
Planned sale10b5-1 planGalectin Therapeutics
Planned sale10b5-1 plan
Galectin Therapeutics
GALT
$282.2K
40,000 sh
$282.2K
Filed 25/12/17
Traded 25/12/17